China Medical System Holdings Limited
China Medical System Holdings Limited (HKSE: 867) is trading at HK$10.44, about ₹129 at today's HKD/INR rate, as of 8 Oct 2026, 4:08 AM ET, down 1.97% today. Indian residents can buy China Medical System from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$10.41
Today's high
HK$10.86
52 week low
HK$9.51
52 week high
HK$15.52
867 opened at HK$10.53, closed previously at HK$10.65, and has traded between HK$9.51 and HK$15.52 over the past 52 weeks.
About
Established in 1995 and headquartered in North Point, Hong Kong, China Medical System Holdings Limited functions as an investment holding company with a primary focus on the development, marketing, and distribution of a wide array of pharmaceutical products throughout the People's Republic of China. The company's extensive portfolio addresses numerous therapeutic areas. Its cardiovascular offerings include Plendil for hypertension and stable angina, XinHuoSu for acute heart failure, and Imdur for coronary heart disease, chronic heart failure, and myocardial infarction prevention. For mental health and neurological support, it provides Deanxit to treat mild-to-moderate depression and anxiety, along with Parlodel tablets for endocrine and neuro system indications. Digestive and liver conditions are managed with products such as Ursofalk for gallstones and cholestatic liver disease, Salofalk for ulcerative colitis and Crohn's disease, Bioflor for diarrhea, Combizym for dyspepsia, and Ganfule capsules for primary liver cancer, plus MOVICOL for chronic constipation. The company also markets Augentropfen Stulln Mono eye drops for senile macula degeneration and asthenopia, Hirudoid for blunt trauma and superficial phlebitis, Elcatonin injection for osteoporosis, and Lamisil tablets for fungal infections. Respiratory issues are addressed by YiNuoShu, while infectious diseases benefit from DanShenTong capsules (for various infections like acne, tonsillitis, and boils) and YinlianQinggan granules for hepatitis. XiDaKang, a protein hydrolysate oral solution, is also part of its offerings. Beyond its pharmaceutical endeavors, the group is also actively involved in agriculture and livestock operations. China Medical System Holdings Limited operates as a subsidiary of Treasure Sea Limited.
Key statistics
Avg. volume
6.21M
Market cap
HK$25.40B
P/E Ratio
14.38
Price-to-sales ratio
2.51
Enterprise value
CN¥26.02B
Free cash flow yield
0.87%
Debt-to-equity ratio
0.05
Return on equity
8.56%
ROIC
5.89%
Beta
1.11
Dividend yield
3.30%
Last dividend
HK$0.34
Financial overview
Revenue
CN¥8.21B
Earnings per share
CN¥0.62
Free cash flow
CN¥244.01M
Net profit margin
17.58%
Gross margin
71.18%
EBITDA
CN¥1.85B
Revenue growth
9.95%
Similar securities
This is not an investment recommendation
How to buy China Medical System from India
Indian residents can buy China Medical System shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in China Medical System from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for China Medical System and place an order
Find China Medical System by name or by its ticker, 867, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. China Medical System trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your China Medical System position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Trading and taxes when buying China Medical System from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. China Medical System’s current yield is 3.30%.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
FAQs
Can Indian residents buy China Medical System stock?
Yes. China Medical System (867) has been listed on the Hong Kong Stock Exchange since 2010, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one China Medical System share cost in rupees?
One China Medical System share is HK$10.44 — about ₹129 at an HKD/INR rate of 12.34 on 7 Oct 2026. Both the China Medical System price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying China Medical System from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of China Medical System?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on China Medical System shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the China Medical System price. Paasa issues a capital-gains statement for your return.
Does China Medical System pay a dividend, and how is it taxed in India?
Yes. China Medical System pays a dividend and the current yield is 3.30%; the last declared dividend was HK$0.34 per share, about ₹4.24. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade China Medical System from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on China Medical System shares held from India?
Hong Kong has no estate duty.
Do I have to declare China Medical System shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your China Medical System holding, its cost and its closing value.
How do I sell China Medical System and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.